Please login to the form below

Not currently logged in
Email:
Password:

antibiotics

This page shows the latest antibiotics news and features for those working in and with pharma, biotech and healthcare.

FDA accepts priority review for Merck’s antibiotic combo Recarbrio

FDA accepts priority review for Merck’s antibiotic combo Recarbrio

The World Health Organization (WHO) has highlighted “in particular the threat of gram-negative bacteria that are resistant to multiple antibiotics. ... This would include an upfront payment made for access to any drugs developed that can treat

Latest news

More from news
Approximately 59 fully matching, plus 283 partially matching documents found.

Latest Intelligence

  • Tackling antimicrobial resistance on multiple fronts Tackling antimicrobial resistance on multiple fronts

    Simply focusing on reduction of volume of antibiotics will not be enough either. ... This pilot project is a good start in demonstrating that new antibiotics will be fairly compensated, but more efforts are needed to stabilise the antibiotic market.

  • The mission matters The mission matters

    The success of vaccines, antibiotics, HIV treatments and many other therapies is evidence of how society has benefited from the deal.

  • #OrkambiNow? #OrkambiNow?

    antibiotics to treat these.

  • Combining therapies and combining research Combining therapies and combining research

    Combination therapy. Antibiotic Combination Therapy was developed in 1952 for the treatment of tuberculosis. ... Of course, other strategies also play their part: improved antibiotic stewardship, good infection control, publicity about AMR, more

  • Nudge-nudge, think-think Nudge-nudge, think-think

    practices and simply explained that they were prescribing antibiotics at a higher rate than other practices in their area.

More from intelligence
Approximately 5 fully matching, plus 37 partially matching documents found.

Latest appointments

  • New faces at 90TEN, Lucid Group and Porterhouse New faces at 90TEN, Lucid Group and Porterhouse

    In that role, Cook delivered initiatives to improve national health, including promoting responsible antibiotic use, protecting against STIs and encouraging rates of childhood immunisation.

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Francesco Maria Lavino joins to support commercialisation of its new antibiotic. ... He said: “Nabriva Therapeutics is poised to introduce what is potentially the first new class of antibiotics for systemic human use in nearly two decades.

  • Destiny Pharma appoints new CEO Destiny Pharma appoints new CEO

    development. He said: “The resistance to antibiotics is becoming a global issue that needs to be addressed and I believe Destiny has a significant part to play.

  • Dr Engelbert Tjeenk Willink joins Allecra Therapeutics Dr Engelbert Tjeenk Willink joins Allecra Therapeutics

    Regulatory authorities have recognised the potential that Allecra’s novel antibiotic may contribute towards solving the crisis of resistant bacterial infections, and out lead development programme has been significantly expedited. ... With these new

  • Micreos appoints chief medical officer Micreos appoints chief medical officer

    In his new role Dr Frieling will be responsible for overseeing Micreos' antibiotic alternative, Staphefekt, as it begins clinical trials.

More from appointments
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 29 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics